Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease?

被引:28
|
作者
Gerson, L. B.
Ullah, N.
Fass, R.
Green, C.
Shetler, K.
Singh, G.
机构
[1] Stanford Univ, Sch Med, Div Gastroenterol, Stanford, CA 94305 USA
[2] Univ Arizona, Sch Med, Div Gastroenterol, Tucson, AZ 85721 USA
[3] So Arizona VA Hlth Care Syst, Tucson, AZ 85721 USA
[4] Calif Pacific Med Ctr, Div Gastroenterol, San Francisco, CA 94115 USA
关键词
D O I
10.1111/j.1365-2036.2007.03290.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Obesity has been demonstrated to be a risk factor for the development of gastro-oesophageal reflux disease (GERD). Aim To perform a prospective cohort study to determine whether there was a difference in body mass index (BMI) between patients with GERD and patients with Barrett's oesophagus (BE). Methods We prospectively enrolled patients undergoing endoscopic evaluation for GERD and collected information regarding BMI, tobacco and/or alcohol use, and family history of GERD. Patients with non-erosive reflux disease underwent confirmatory 24-h pH testing. Results Seven hundred and fifty one patients with GERD (mean +/- s.d. age of 55.4 +/- 14.2 years, 74% male) entered the study, and BE was present in 165 (22%, 90% male, 79% Caucasian) patients. The mean GERD symptom duration was 10.3 +/- 0.4 years (range 1-62 years) with a mean body mass index of 27.8 +/- 0.2 kg/m(2) (range 15-55) Compared with patients having GERD alone, patients with BE were more likely to be older (P = 0.001), male (P < 0.001), current or prior tobacco users (P = 0.002), and with greater duration of GERD symptoms (P < 0.001). There was no significant difference in the BMI for patients with and without BE. Conclusions While obesity is a risk factor for both GERD and BMI, patients with BE did not demonstrate increased BMI compared with patients having chronic GERD.
引用
收藏
页码:1079 / 1086
页数:8
相关论文
共 50 条
  • [1] Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
    Stoltey, J.
    Reeba, H.
    Ullah, N.
    Sabhaie, P.
    Gerson, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (01) : 83 - 91
  • [2] Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus
    Wurm, P
    de Caestecker, J
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (07) : 1049 - 1061
  • [3] Oesophageal capsule endoscopy in patients with gastro-oesophageal reflux disease and Barrett's oesophagus: improvement of diagnostic accuracy
    de Jonge, P. J. F.
    van Eijck, B. C.
    Geldof, H.
    Bekkering, F. C.
    Kuipers, E. J.
    Siersema, P. D.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A65 - A65
  • [4] Risk of oesophageal cancer in Barrett's oesophagus and in gastro-oesophageal reflux
    Solaymani-Dodaran, M
    Coupland, C
    Logan, RFA
    GASTROENTEROLOGY, 2003, 124 (04) : A33 - A33
  • [5] Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux
    Solaymani-Dodaran, M
    Logan, RFA
    West, J
    Card, T
    Coupland, C
    GUT, 2004, 53 (08) : 1070 - 1074
  • [6] Risk of oesophageal cancer in Barrett's oesophagus and in gastro-oesophageal reflux
    Solaymani-Dodaran, M
    Coupland, C
    Logan, RFA
    GUT, 2003, 52 : A20 - A20
  • [7] Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease
    Britton, James
    Gadeke, Lisa
    Lovat, Laurence
    Hamdy, Shaheen
    Hawkey, Chris
    McLaughlin, John
    Ang, Yeng
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (11): : 824 - 831
  • [8] Oesophagitis and Barrett's oesophagus - Are they related to the pattern of gastro-oesophageal reflux?
    Jalal, PK
    Dwarakanath, AD
    Tanner, AR
    GASTROENTEROLOGY, 2000, 118 (04) : A1252 - A1252
  • [9] Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors
    Gerson, LB
    Boparai, V
    Ullah, N
    Triadafilopoulos, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (06) : 637 - 643
  • [10] Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett's oesophagus
    Kountouras, Jannis
    Chatzopoulos, Dimitrios
    Zavos, Christos
    MEDICAL HYPOTHESES, 2007, 68 (05) : 1174 - 1175